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446a Tuesday, February 5, 2013from RyR1 enhances the L-type Ca2þ current via the DHPR. RyR1 (5,037
residues) assembles as a homotetramer in which the C-termini form the ion
conducting pore across the SR membrane, with the remainder of the protein
forming a ‘‘foot’’ structure which spans between the SR and plasma mem-
branes. In an accompanying abstract (Polster et al., this meeting) we showed
that a construct (YFP-RyR11:4300) which lacks the C-terminal residues was
diffusely distributed in dysgenic myotubes (DHPR null), but that in dyspedic
myotubes (RyR1-null but containing DHPRs) it targeted junctionally and
retrogradely enhanced L-type Ca2þ current. Here we have examined the oligor-
merization of YFP-RyR11:4300. Measurement of FRAP for YFP-RyR11:4300 in
dysgenic myotubes yielded a diffusion coefficient of 2.17x108 cm2/sec,
which, based on previous measurements of protein diffusion in muscle, is
compatible with YFP-RyR11:4300 existing as a tetramer. We also used SDS
PAGE (4-15% gradient) and immunoblotting to compare YFP-RyR11:4300
(expressed in tsA-201 cells) and native RyR1. Without prior cross-linking,
YFP-RyR11:4300 displayed a smaller apparent MW than wt RyR1; after glutar-
aldehyde cross-linking, both proteins migrated as single bands of much higher
apparent MW, with YFP-RyR11:4300 again displaying a slightly greater mobil-
ity, consistent with it’s being a tetramer.
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A RyR1 construct that lacks the channel forming C-terminal residues but in-
cludes the entire cytoplasmic foot region (YFP-RyR11:4300) forms a stable tet-
rameric structure (H. Bichraoui et al., abstract this meeting), colocalizes with
DHPRs at SR/plasmalemma junctions and retrogradely enhances peak DHPR
currents when expressed in dyspedic (RyR1 null) myotubes (A. Polster et al.,
abstract this meeting). We tested the interaction of the expressed RyR11:4300
with DHPRs in dyspedic myotubes by examining the DHPR disposition using
freeze-fracture. Normally DHPRs are targeted to junctional sites in the absence
of RyR, but their organization into tetrads and the arrangement of tetrads in
ordered arrays is strictly dependent on their link to arrays of tetrameric
RyRs. Thus the disposition of DHPRs in freeze-fracture images provides direct
information both on DHPR/RyR interaction and on the arrangement of RyRs.
In dyspedic cells DHPR clusters at peripheral couplings in a loose, completely
random arrangement. Cells expressing full-length RyR1 show more tightly
clustered DHPRs and the presence of complete (4 elements) and incomplete
(2-3 elements) tetrads that are aligned in an orthogonal array. Cells expressing
the truncated RyR11:4300 show small well identifiable DHPR foci with closely
spaced particles. Some but not all foci show clear grouping of DHPRs into
complete tetrads and/or tetrads composed of only three elements, but the tetrads
are not aligned into a orthogonal array. We conclude that similar to intact
RyR1, RyR11:4300 forms homo-tetramers which can link to DHPRs and orga-
nize them into tetrads, but that the cytoplasmic RyR1 foot differs from full-
length RyR1 in that it does not form orthogonal arrays. The related positioning
of RyR11:4300 and DHPRs is necessary for the retrograde interaction between
the two.
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Skeletal (RyR1) and cardiac muscle (RyR2) isoforms of ryanodine receptor
calcium channels are ~65 % homologous in amino acid sequences; however
they differ in their regulation by endogenous molecules and proteins. Both
RyR1 and RyR2 are inhibited by millimollar Ca2þ, but RyR2 affinity for
inhibitory Ca2þ is ~10 times lower than RyR1. Previous studies demonstrated
that C-terminus quarter of RyR has critical domain(s) for Ca2þ inactivation
(Du and MacLennan (1999) J. Biol. Chem.274, 26120; Nakai et al. (1999)
FEBS Lett.459, 154). We pursued these observations to obtain further insights
into RyR regulation by Ca2þ. We constructed and expressed 8 RyR1/RyR2
chimeras in HEK293 cells and determined Ca2þ activation and inactivation
affinities of these channels by [3H]ryanodine ligand binding method. We
found that replacing two regions of RyR1 with corresponding RyR2 sequence
reduced the affinity for Ca2þ inactivation. The first region (RyR2 amino acid
4020-4250) contains two EF hand Ca2þ binding motifs (EF1: 4036-4047,
EF2: 4071-4082). Another chimera containing only EF2 of RyR2 (RyR2
4053-4250) has only a modest (not significant) change in Ca2þ inactivation.The results suggest that EF1 is a critical determinant for RyR inactivation
by Ca2þ. Consistently, a chimera channel carrying only RyR2-EF1 (RyR2
3692-4052) showed significantly reduced Ca2þ inactivation, whereas a chi-
mera carrying RyR2 3692-4019 (no EF hands) behaved essentially as
RyR1. Second, preliminary studies indicate that substitution of the last
~450 amino acids of RyR1 with corresponding RyR2 (4521-4968) results in
Ca2þ inactivation affinity between RyR1 and RyR2. Replacing both regions
in RyR1 with RyR2 sequences (4020-4250 and 4521-4968) further reduced
Ca2þ inactivation affinity, which suggests that in addition to EF1, C-terminal
~450 amino acids have a role in Ca2þ-dependent inactivation of RyRs.
Supported by NIH, AHA and NSF.
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Using fluorescence resonance energy transfer (FRET), we are testing the hy-
pothesis that S100A1 competes with calmodulin (CaM) for binding to cardiac
ryanodine receptors (RyR2). In isolated pig cardiac sarcoplasmic reticulum
(SR) vesicles, we targeted a donor-labeled FKBP (D-FKBP) to the RyR2
cytosolic headpiece. We then detected FRET as a decrease of donor fluores-
cence in the presence of CaM labeled with acceptor within the N- or C-lobe
(denoted AN-CaM and AC-CaM, respectively), thus directly and specifically
indexing CaM binding in the proximity of D-FKBP. FRET between
D-FKBP and A-CaMs (100 nM) was completely inhibited by unlabeled
WT-CaM, with KIz 100 nM, indicating that WT-CaM and A-CaMs compete
with similar affinities for the same RyR2 binding site. However, S100A1
(ranging from 0.1 to 30 mM) had no significant effect on FRET when cardiac
SR was concurrently incubated with S100A1 and AN-CaM. Upon sequentially
incubating the SR with S100A1 first, then with AN-CaM, we found partial
inhibition of FRET, but with KI z 30 mM S100A1. This effect is more pro-
nounced in nM Ca2þ (versus mM Ca2þ). Intriguingly, FRET between D-FKBP
and AC-CaM was not significantly affected by S100A1. S100A1 lowered
maximum FRET for AN-CaM but did not significantly change its binding
affinity. This suggests that S100A1 allosterically interacts with RyR-CaM
binding, rather than directly competing for the same binding site as CaM.
We are currently developing a complementary FRET approach, using
acceptor-labeled S100A1, to specifically resolve the S100A1 binding to
RyR. Ultimately, we aim to elucidate the interplay between S100A1 and
CaM binding to RyR.
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We have reported that CGP-37157, a benzothiazepine (BZT) derivative of
clonazepam utilized as a blocker of the mitochondrial Naþ/Ca2þ exchanger,
also activates ryanodine receptors (RyRs) and inhibits the sarcoplasmic retic-
ulum (SR) Ca2þ-stimulated ATPase (SERCA). We extended the studies to
other BZT (e.g., clonazepan, diltiazem) as well as to benzodiazepines
(BZD; e.g. diazepan, lorazepan). We aimed to determine if these drug classes
have as a common trait the ability to modulate RyRs and/or SERCA. The
effects of BZD and BZT on RyRs activity were tested in SR microsomes
with a Ca2þ leak assay as well as after reconstituting RyRs into lipid bilayers.
The agents tested had variable potency to increase RyR-mediated Ca2þ leak
from skeletal SR microsomes. As an example, while diazepam significantly
increased RyR activity, most of the others (clonazepam, lorazepam) had
minor effects at high doses. In contrast, diltiazem produced moderate inhibi-
tion. Planar bilayer studies confirmed the leak observations with both cardiac
and skeletal RyR. In the presence of ruthenium red, most agents decreased
the rate of loading which indicates inhibitory effects on SERCA activity.
The effects of BZT and BZD on loading correlated with a decrease in
ATPase activity of SERCA-enriched skeletal SR fractions. In summary,
most BZT and BZD utilized in therapeutics or as pharmacological tools
have an inhibitory action on SERCA. In contrast, they show a variety of ef-
fects on RyRs ranging from inhibition to activation. Hence, the pharmacolog-
ical action of BZT and BZD on cellular Ca2þ homeostasis reported in the
literature of cardiac and skeletal muscle as well as other non-muscle systems
may require taking into consideration the contributions of all drug-sensitive
intracellular Ca2þ transporters. (Supported by NIH-GM078665 and AHA-
MWA 12180038).
